Literature DB >> 26785109

Clinical Decision Support Tools: The Evolution of a Revolution.

D R Mould1, G D'Haens2, R N Upton1,3.   

Abstract

Dashboard systems for clinical decision support integrate data from multiple sources. These systems, the newest in a long line of dose calculators and other decision support tools, utilize Bayesian approaches to fully individualize dosing using information gathered through therapeutic drug monitoring. In the treatment of inflammatory bowel disease patients with infliximab, dashboards may reduce therapeutic failures and treatment costs. The history and future development of modern Bayesian dashboard systems is described.
© 2015, The American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26785109     DOI： 10.1002/cpt.334

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  26 in total

1.  Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.

Authors:  Susanne B Haga; Rachel Mills; Jivan Moaddeb; Nancy Allen LaPointe; Alex Cho; Geoffrey S Ginsburg
Journal:  Pharmacogenomics       Date:  2017-02-22       Impact factor: 2.533

2.  Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease.

Authors:  Adam Frymoyer; Daniël R Hoekman; Travis L Piester; Tim G de Meij; Thalia Z Hummel; Marc A Benninga; Angelika Kindermann; K T Park
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-12       Impact factor: 2.839

3.  Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies.

Authors:  Jessica Wojciechowski; Richard N Upton; Diane R Mould; Michael D Wiese; David J R Foster
Journal:  AAPS J       Date:  2017-04-25       Impact factor: 4.009

4.  Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Kana Mizuno; Min Dong; Tsuyoshi Fukuda; Sharat Chandra; Parinda A Mehta; Scott McConnell; Elias J Anaissie; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

5.  Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations.

Authors:  Yu Cheng; Chen-Yu Wang; Zi-Ran Li; Yan Pan; Mao-Bai Liu; Zheng Jiao
Journal:  Clin Pharmacokinet       Date:  2021-01       Impact factor: 6.447

Review 6.  Learning Health Systems as Facilitators of Precision Medicine.

Authors:  L B Ramsey; T Mizuno; A A Vinks; P A Margolis
Journal:  Clin Pharmacol Ther       Date:  2017-03       Impact factor: 6.875

7.  Optimising infliximab induction dosing for patients with ulcerative colitis.

Authors:  Erwin Dreesen; Ruben Faelens; Gert Van Assche; Marc Ferrante; Séverine Vermeire; Ann Gils; Thomas Bouillon
Journal:  Br J Clin Pharmacol       Date:  2019-02-10       Impact factor: 4.335

8.  Ordering of computed tomography scans for head and cervical spine: a qualitative study exploring influences on doctors' decision-making.

Authors:  H Laetitia Hattingh; Zoe Alexandra Michaleff; Peter Fawzy; Leanne Du; Karlene Willcocks; K Meng Tan; Gerben Keijzers
Journal:  BMC Health Serv Res       Date:  2022-06-18       Impact factor: 2.908

9.  External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.

Authors:  Jun-Jun Mao; Zheng Jiao; Hwi-Yeol Yun; Chen-Yan Zhao; Han-Chao Chen; Xiao-Yan Qiu; Ming-Kang Zhong
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

Review 10.  Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.

Authors:  Joshua C Euteneuer; Suyog Kamatkar; Tsuyoshi Fukuda; Alexander A Vinks; Henry T Akinbi
Journal:  J Clin Pharmacol       Date:  2018-09-11       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.